Carcinoma pseudopapilar sólido del páncreas / Solid pseudo-papillary carcinoma of the pancreas

El tumor sólido pseudopapilar del páncreas, conocido también como tumor de Frantz, es una enfermedad rara: neoplasia bien delimitada, de lento crecimiento, no agresiva pero maligna, habitualmente con pronóstico favorable. El tratamiento de elección es quirúrgico. Aunque algunos de ellos son agresivos a nivel local, la mayoría de los pacientes se curan con la resección completa del tumor. Se reportó el caso de una mujer de 30 años, ingresada en el Servicio de Cirugía General del Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández, con diagnóstico presuntivo clínico e imagenológico, de tumor pseudopapilar sólido del páncreas, con confirmación histológica tras la resección quirúrgica. Este infrecuente tumor debe ser considerado en el diagnóstico diferencial de los tumores pancreáticos, fundamentalmente en mujeres jóvenes(AU)

The solid pseudo-papillary carcinoma, also known as Frantz´s tumor, is a rare disease. It is a well-defined neoplasia, of low growth, non-aggressive but malignant, usually with a favorable prognosis. The elective treatment is the surgery. Although some of them are locally aggressive, most patients are healed with the complete tumor resection. The authors reported the case of a woman, aged 30 years who entered the Service of General Surgery of the University Hospital Comandante Faustino Pérez Hernández, with a presumptive clinical and imaging diagnosis of pancreas solid pseudo-papillary tumor, histologically confirmed after surgical resection. This infrequent tumor should be taken into account in the differential diagnosis of pancreatic tumors, mainly in young women(AU)

Analgesia multidimensional para los pacientes en estadio terminal por cáncer de páncreas / Multidimensional analgesia for terminal stage patients with pancreatic cancer

RESUMEN Introducción: el cáncer es la segunda causa de muerte en el mundo; los tumores del sistema digestivo ocupan el segundo lugar y según localización los de páncreas poseen la menor tasa de supervivencia. Objetivo: evaluar la efectividad de la analgesia multidimensional para los pacientes en estadio terminal por cáncer de páncreas. Métodos: se realizó un estudio cuasiexperimental, comparativo, prospectivo y longitudinal en pacientes con dolor por tumor de páncreas en etapa final de su enfermedad, en el Hospital Abel Santamaria Cuadrado desde noviembre 2016 a julio 2019. Se incluyeron todos los pacientes con dolor por tumor de páncreas en estadio terminal, se conformaron tres grupos de acuerdo con el método de analgesia empleado; Grupo I (n=10) analgesia multimodal, Grupo II (n=10) analgesia multidimensional y Grupo III (n=3) esquema de analgesia de la Organización Mundial de la Salud, se evaluó calidad de la analgesia, la necesidad de dosis de rescate y uso de morfina, se compararon los métodos y se determinó la supervivencia. Resultados: la calidad de la analgesia fue mayor en los pacientes del grupo II, en igual grupo no fue necesario el uso de morfina hasta el 7mo mes y en solo dos pacientes, (p=0,00) no hubo diferencias en las tasas de supervivencia. Conclusiones: el enfoque multidimensional de la analgesia, donde se incluya al individuo como ser biopsicosocial y a la familia, logra mayor calidad de la analgesia. El método empleado para el alivio del dolor no influye en la supervivencia.

ABSTRACT Introduction: cancer is the second leading cause of death in the world; the tumors of the digestive system occupy the second place and according to itslocation, those in the pancreas have the lowest survival rate. Objective: to assess the effectiveness of multidimensional analgesia for patients in terminal stage due to pancreatic cancer. Methods: a quasi-experimental, comparative, prospective and longitudinal study was conducted in patients with pain due to pancreatic tumor in terminal stage at Abel Santamaria Cuadrado General Teaching Hospital from November 2016 to July 2019; all patients with pain due topancreatictumor were included. In the terminal stage of pancreatic cancer, three (3) groups were completed according to the analgesia method applied; Group I (n = 10) multimodal analgesia, Group II (n = 10) multidimensional analgesia and Group III (n = 3) following WHO analgesia scheme, analgesia quality, and the need for rescue dose and application of morphine, the methods were compared and survival rate was determined. Results: the quality of analgesia was higher in patients from group II, in the same group the application of morphine was not required until the 7th month and in only two patients (p = 0.00), there were no differences in the rates of survival. Conclusions: the multidimensional approach to analgesia, where the individual is included as a biopsychosocial being and the family achieves greater quality of analgesia, the method applied for pain relief does not influence on survival.

Neurolisis del plexo celiaco en cáncer de páncreas / Neurolysis of the celiac plexus in pancreas cancer

Introducción: El cáncer en Cuba constituye la primera causa de mortalidad en edades de 15 a 64 años y la segunda en mayores de 65, los tumores digestivos ocupan la tercera posición en las neoplasias malignas y la afección pancreática el cuarto lugar dentro de estas. Objetivo: Presentar la evolución de un paciente con un tumor de páncreas y una supervivencia de más de 6 meses al cual se le realizó neurolisis del plexo celiaco. Presentación del caso: Paciente masculino de 64 años de edad con el diagnóstico de adenocarcinoma de cuerpo y cola de páncreas sin criterio quirúrgico con dolor de severa intensidad que imposibilita el inicio del tratamiento adyuvante para lo cual se le realizó neurolisis del plexo celiaco bilateral, con 7 mL de fenol al 10 por ciento por cada lado, vía posterior retrocrural bajo seguimiento con intensificador de imágenes, y se administró tratamiento coadyuvante vía oral a base de antidepresivos tricíclicos, analgésicos y ansiolíticos debido al componente mixto del dolor oncológico. Conclusiones: El bloqueo neurolitico del plexo celiaco asociado a terapia farmacológica analgésica convencional por vía oral proporcionó un alivio total del dolor por neoplasia de páncreas de forma inmediata y duradera, se logró mejorar el estado general del paciente lo cual facilitó el inicio de la terapia adyuvante oncológica(AU)

Introduction: In Cuba, cancer is the leading cause of death at ages 15-64 and the second at ages over 65, digestive tumors occupy the third position among malignancies and pancreatic affection the fourth place among these. Objective: To present the evolution of a patient with a pancreatic tumor and survival of more than 6 months who underwent neurolysis of the celiac plexus. Case presentation: A 64-year-old male patient diagnosed with adenocarcinoma of the body and tail of the pancreas without surgical criteria, with pain of severe intensity that made it impossible to start adjuvant treatment, for which he underwent neurolysis of the bilateral celiac plexus, with 7 mL of phenol-10 percent per side, through the retrocrural posterior space with follow-up with image intensifier, and oral adjuvant treatment was administered with tricyclic, analgesic and anxiolytic antidepressants due to the mixed component of oncological pain. Conclusions: The neurolytic block of the celiac plexus associated with conventional oral analgesic pharmacological therapy provided total relief of pain from pancreatic cancer in an immediate and lasting way. It was possible to improve the general state of the patient, which facilitates the start of adjuvant oncology therapy(AU)

Correlation between preoperative blood glucose level and clinicopathologic characteristics of pancreatic cancer / 西安交通大学学报(医学版)

Objective: To analyze the clinicopathologic characteristics of pancreatic cancer patients and explore the relationship between preoperative blood glucose level and prognosis of pancreatic cancer. Methods: The clinical data of 267 patients treated in The First Affiliated Hospital of Xi'an Jiaotong University from January 2015 to September 2016 were collected and retrospectively analyzed. We also studied the correlation between preoperative blood glucose level and clinicopathologic characteristics of pancreatic cancer. Results: For the study we selected 110 patients (68 males and 42 females) aged between 41 and 84 years with the mean age of (61.34±10.33) years. Among them, 74 (67.27%) of them had preoperative blood glucose level (>6.1 mmol/L) higher than normal level. In addition, 57 patients (51.81%) and 33 patients (30.0%) had CEA level and CA125 level significantly higher than normal and 83 patients (75.45%) had higher CA199 level. There were 56 patients (50.91%)with tumor size over 3 cm and 73 (66.36%) with the tumor located in the head of pancreas. There were 92.73% of patients diagnosed with adenocarcinoma, 2.73% with squamous carcinoma, 2.73% with adenosquamous carcinoma and 1.81% with mucinous cystadenocarcinoma. As for pathological grading, there were 6 cases diagnosed with highly differentiated tumors, 65 cases moderate, 12 moderate to low differentiated, and 27 lowly differentiated tumors. For clinical stage, 2, 13, 27, 20, 15 and 33 patients were detected in stage A, IIIB, ⅡA, ⅡB, III and , respectively. In addition, there were 19 patients detected with lymph node metastases, 22 with distal metastases and 22 with neural invasion. All the 110 patients were followed up effectively, with the average follow-up duration of (4.6±3.8) months. Until the last time we followed up all the patients, we found the tumor relapsed in 14 patients. The median survival time of patients with normal blood glucose was 10 months, while it was only 4 months in patients with high blood glucose. Preoperative blood glucose level was closely related with the patients' prognosis and tumor size, TNM stage, distal metastasis, lymph node metastasis, and neural invasion. Conclusion: High blood glucose level is one of the risk factors for the poor prognosis of pancreatic cancer.

Feasibility analysis and safety of laparoscopic pylorus-preserving pancreaticoduodenectomy / 局解手术学杂志

Objective To investigate the safety and feasibility of laparoscopic pylorus-preserving pancreaticoduodenectomy.MethodsThe data of 59 patients with laparoscopic pancreaticoduodenectomy in Shangjin hospital of West China hospital of Sichuan University from January 2014 to December 2015 were analyzed retrospectively.The general data,operative time,estimated blood loss,conversion rate,time to liquid diet,postoperative hospital stay and complications were analyzed.Results The laparoscopic pylorus-preserving pancreaticoduodenectomy were successfully performed in 56 cases,the successful rate was 94.9%,the other 3 patients were converted to laparotomy for superior mesenteric vein/portal vein involvement.The operative time was 255~510 minutes,with mean operative time (384±145) minutes,the intraoperatve blood soss was 50~800 mL,with mean estimated blood loss (148±28)mL,the time to liquid diet was 1.0~4.0 days,with average time (3.2±1.1)days,the postoperative hospital stay was 5.0~53.0 days,with average time (10.3±2.6)days.After surgery,16 cases suffered from complication,the rate was 27.1%.The most common complication was pancreatic fistula which occurred in 13 cases including 12 cases of grade A and 1 case of grade pancreatic fistula.No grade C pancreatic fistula occurred in this series.Six patients suffered from delayed gastric emptying.One patient suffered from bile leakage.Conclusion Laparoscopic pylorus-preserving pancreaticoduodenectomy was safe and feasible.Pylorus-preserving does not increase the incidence of delayed gastric emptying.

Ten-year case review of solid-pseudopapillary neoplasm of pancreas / 西安交通大学学报(医学版)

Objective To summarize the methods of diagnosing and treating solid-pseudopapillary neoplasm of pancreas SPN so as to provide reference for its early clinical diagnosis.Methods We collected the clinical data of 62 patients with pathologically confirmed diagnosis of SPN treated in the First Affiliated Hospital of Xi'an Jiaotong University between Feb.2004 and Sep.2014.Then we retroactively analyzed and summarized the clinical characteristics,diagnosis and treatment of the disease.Results Among the 62 patients,55 were female and 7 were male;the mean age was (31.58±12.67) years old.The clinical features showed no specificity and the tumor was mostly detected upon physical check-up.The tumor was seen to be located mostly in the body and tail of the pancreas,and the average maximum diameter was (7.81±3.54)cm.We did not find obvious abnormality in routine pre-operative blood test results or liver and kidney functions.The imageological examination indicated tumor occupation in the pancreas.All the patients underwent surgical resection with no complications or death and had a good recovery after operation.Pathological diagnosis after operation was SPN without metastasis in lymph modes.Until the last time we followed up all the patients,we found relapse in two patients (3.2％).Conclusion SPN is a tumor that tends to affect young and middle-aged females.The malignancy grade of SPN is low,and patients with this disease show no specificity in clinical manifestation.The imageological examination is of vital importance in diagnosing SPN and surgical resection is an effective way to treat SPN.

Evaluation of 99mTc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice

Pancreatic adenocarcinoma is important in oncology because of its high mortality rate. Deaths may be avoided if an early diagnosis could be achieved. Several types of tumors overexpress gastrin-releasing peptide receptors (GRPr), including pancreatic cancer cells. Thus, a radiolabeled peptide derivative of gastrin-releasing peptide (GRP) may be useful as a specific imaging probe. The purpose of the present study was to evaluate the feasibility of using99mTc-HYNIC-βAla-Bombesin(7-14)as an imaging probe for Capan-1 pancreatic adenocarcinoma. Xenographic pancreatic tumor was developed in nude mice and characterized by histopathological analysis. Biodistribution studies and scintigraphic images were carried out in tumor-bearing nude mice. The two methods showed higher uptake by pancreatic tumor when compared to muscle (used as control), and the tumor-to-muscle ratio indicated that99mTc-HYNIC-βAla-Bombesin(7-14)uptake was four-fold higher in tumor cells than in other tissues. Scintigraphic images also showed a clear signal at the tumor site. The present data indicate that99mTc-HYNIC-βAla-Bombesin(7-14)may be useful for the detection of pancreatic adenocarcinoma.

Tumor sólido pseudopapilar de pâncreas: relato de um caso com apresentação incomum / Solid pseudopapillary tumor of the pancreas: report of one uncommon presentation case

Caso clínico atípico de tumor sólido pseudopapilar de pâncreas (TSPPP) acometendo paciente do sexo masculino, 37 anos, com quadro inicial de dor abdominal aguda. Após cirurgia e exame anatomopatológico com imuno-histoquímica, demonstrou padrão condizente com TSPPP e forte positividade para β-catenina. Dois anos após a cirurgia o paciente encontra-se livre de recidiva. O TSPPP é mais comum em mulheres jovens com quadro clínico de massa ou desconforto abdominal, podendo alguns casos ser assintomáticos. Apresenta crescimento lento e baixo potencial de malignidade, sendo a ressecção cirúrgica o tratamento de escolha com altos índices de cura.

Atypical clinical case of solid pseudopapillary tumor (SPPT) of the pancreas in a 37 year-old man with acute abdominal pain. After surgery, anatomopathologic investigation with immunohistochemistry showed pattern in keeping with SPPT and strong positivity for β-catenin. Two years post-surgery the patient does not present recurrence. The SPPT normally occurs in young women with a history of mass or abdominal discomfort, although in some cases it can be asymptomatic. The tumor has slow growth, low potential for malignancy and surgical resection yields high cure rates.

A case of the extrapulmonary paragonimiasis presenting as pancreatic tumor / 대한내과학회지

Pancreatic tumor has a wide range of differential diagnosis, from the benign inflammatory diseases, to the malignant disease such as pancreatic cancer. Here, we report a case of extrapulmonary paragonimiasis involving pancreas which was difficult to differentiate from primary neoplasm of pancreas. A 44 year old man was presented with a pancreatic tumor having inhomogenous enhancement and cystic nature in part, and conglomerated mass with rim enhancement and central hypodensity along both anterior and posterior side of pancreas on CT. No diagnostic clue was obtained from those conventional procedures and then the surgical exploration was perfomed to confirm the histology. The pathologic finding revealed the Paragonimus eggs in the granulomatous inflammation with necrosis.

Endocrine Tumors of the Pancreas Secreting Multiple Hormones / 대한내분비학회지

BACKGROUND: Endocrine pancreas tumor is a rare disease which incidence is less than 2% of all pancreatic tumors. But it comprises various types of tumor and usually secretes several hormones from one type of tumor although the patient with this tumor complains of sole symptom associated with only one hormone. The mechanism and clinical significance of multiple hormone secretion in the endocrine pancreas tumom are not yet clearly defined. METHODS: We analyzed retrospectively the clinicopathologic features of 20 cases which were operated at Seoul National University Hospital during the period between February 1989 and May 1998. RESULTS: The most common tumor was insulinoma (13 cases) and the second most common tumor was nonfunctioning tumor (6 cases). There was one case of somatostatinoma. Most of the patients with insulinoma complained of neuroglycopenic symptoms. There were 9 cases (45.0%) in which the tumors secreted more than two kinds of hormones, 7 cases in insulinoma, 2 cases in nonfunctioning tumors. Whether the tumor secreted multiple hormones was detected by the method of immunohistochemical staining. Though the tumors secreted more than two kinds of hormones, the patients with the tumors complained of symptoms which were associated with the cell type most strongly stained by immunohistochemical method. Whether or not the tumors secreted multiple hormones was not associated with the pathologic features such as tumor size, histologic patterns of the tumor, status of tumor cell differentiation and malignancy. CONCLUSION: From this results, we suggest that endocrine tumors of the pancreas secreted multiple hormones not by the mechanism of dedifferentiation from already differentiated endocrine cells but by the mechanism of neogenesis of multipotent islet stem cells. Since the relationship between the function of multiple hormone secretion in the endocrine pancreas tumors and islet stem cell would be significant, further study should be needed to find out the function of stem cells and application of stem cells to clinical use.

A Clinical Study of Diagnosis and Therapy of Insulinoma (Ten Cases Report) / 昆明医科大学学报

In this paper we repaort ten cases of Insulinoma (one malignant case), of which nine cases were verified by means of operation and pathology. The clinical manifestations, diagnosis, tumor location, interoperative supervission and postoperative complications, etc. were discussed in detail combined with the cases reported. Some insulinomas are difficult to find out in the course of the operation. A suggestion of using fine needle biopsy to detect the suspicious nods in pancreas and removing blood sample from the portal vein to detect the concentration of the insulin was advocated.